Clinical Trial: Hydrocortisone vs. Pasireotide in Preventing Pancreatic Surgery Complications

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Hydrocortisone vs Pasireotide in Preventing Pancreatic Fistula and Other Complications After Pancreatic Resection - a Prospective, Randomized, Controlled Trial

Brief Summary: Pancreatic resections carry a high risk for complications, especially pancreatic fistula. Both hydrocortisone and pasireotide have been shown to be effective in reducing complications in earlier RCTs. The aim of this study is to compare the effectiveness and safety of these two drugs in preventing complications of pancreatic surgery.